CellType
The agentic drug company. We simulate human biology.
New York City, NY
2 employees
Healthcare
Pre-seed
About CellType
The agentic drug company. We simulate human biology.
The agentic drug company. We simulate human biology.
The agentic drug company. We simulate human biology.
Last stage
Pre-seed
Investors
Ivan Vrkic
Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.
David van Dijk
Yale professor with over 11,000 citations who has published in Cell, Nature, ICML, and NeurIPS.
Ivan Vrkic
Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.
LinkedIn
David van Dijk
Co-Founder & CEO of CellType (W26). Yale Professor, 11,000+ citations. Built biological foundation models with Google. Building the agentic drug company.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.